Abstract: The invention relates to novel functional amphiphilic molecule or macromolecule formulations with multiple compartments for transporting or targeting at least one therapeutic agent, in particular an antitumor agent, as well as to a method for preparing such formulations and to the use thereof.
Type:
Grant
Filed:
May 28, 2010
Date of Patent:
June 9, 2015
Assignees:
UNIVERSITE d'AIX-MARSEILLE, UNIVERSITE DE BORDEAUX
Inventors:
Philippe Barthelemy, Salim Khiati, Michel Camplo
Abstract: The present invention relates to herbicidal compositions comprising aminophosphate or aminophosphonate salts, particularly to herbicidal compositions comprising a high amount and aminophosphate or aminophosphonate salts and a betaine surfactant and an amine oxide surfactant.
Type:
Grant
Filed:
December 30, 2005
Date of Patent:
June 2, 2015
Assignee:
RHODIA CHIMIE
Inventors:
Paul Gioia, Poay Huang Chuah, Wenbing Xie
Abstract: Disclosed is an anhydrous lipstick comprising a combination of active ingredients comprising Portulaca pilosa extract, sunflower oil, jojoba esters, mango butter, and tocopherol and a dermatologically acceptable carrier comprising glyceryl behenate/eicosadioate.
Abstract: In the growing of crops for consumption, a method for the removal of pathogens includes the addition to irrigation water for the crops of an anti-pathogen composition and supplying the anti-pathogen composition to the crops prior to harvest while normal irrigation is effected. The anti-pathogen composition is based on halogens, such as chlorine, bromine and iodine, or mixtures of halogens or halogens combined with other organic radicals including cyanurate, hydantoin, peroxide and chlorine dioxide. BCDMH and TICA are preferred anti-pathogen components of the anti-pathogen composition and may be added to a carrier concentrate and measured and dosed into the irrigation water.
Abstract: A method of producing an emulsion includes preparing a droplet solution comprising first and second molecular species, the droplet solution being in a fluid phase, wherein the first molecular species is soluble in the second molecular species; forming a plurality of droplets from the droplet solution in a bulk fluid to create a first emulsion, the plurality of droplets having a first ensemble average radius in the bulk fluid, wherein the first molecular species of the droplet solution is at least partially soluble in the bulk fluid and the droplet solution is at least partially immiscible in the bulk fluid; and allowing molecules of the first molecular species to migrate from the plurality of fluid droplets to the bulk fluid due to a higher concentration of the first molecular species in the droplet solution than the bulk fluid to result in the plurality of droplets having a second ensemble average radius that is smaller than the first ensemble average radius.
Type:
Grant
Filed:
June 17, 2009
Date of Patent:
April 7, 2015
Assignee:
The Regents of the University of California
Abstract: An enteric formulation of duloxetine, its core and preparing method thereof are disclosed. The core comprises duloxetine or its salt and pharmaceutically acceptable excipients. The excipients include water-soluble hot melt materials selected from PEG, poloxamer, polyoxyl (40) stearate or their mixture. Based on the total weight of the core, the amount of water-soluble hot melt materials is 10%˜40% and the amount of duloxetine or its salt is 15˜60%. The core material is prepared by hot melt process. The enteric formulation comprises the core, a separating layer and an enteric layer.
Abstract: A catheter lock solution includes a hydrochloric acid solution having a concentration of 0.3 Molar to 1.0 Molar. This hydrochloric acid solution may be used to lock a catheter and/or salvage an infected catheter.
Type:
Grant
Filed:
August 3, 2010
Date of Patent:
February 10, 2015
Assignee:
Teleflex Medical Incorporated
Inventors:
Nisha Gupta, Elaine Steinke, Joel Rosenblatt
Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
Abstract: A composition having a germination-preventing activity, comprising, as active principle, allyl isothiocyanate alone or in combination with other substances having a synergic action, in the form of emulsifiable formulates or as a microencapsulate in which allyl isothiocyanate is englobed in a polymeric-based system for the controlled release of the active principle. The microcapsule membrane represents a weight percentage of 5-25%, the surfactant 2-10% and allyl isothiocyanate a weight percentage not lower than 70%.
Type:
Grant
Filed:
June 26, 2007
Date of Patent:
December 2, 2014
Assignee:
Isagro S.p.A.
Inventors:
Francesco Guariglia, Pio Iannelli, Paola Scarfato
Abstract: Provided is a herbicidal composition comprising a herbicidally active compound selected from a difluoromethanesulfonylanilide compound represented by the general formula (I): wherein R1 represents a hydrogen atom, an alkyl group or an alkoxyalkyl group; or a salt thereof encapsulated in a microcapsule, or a herbicidal composition comprising the herbicidally active compound encapsulated in a microcapsule and a benzoic acid compound represented by the general formula (II): wherein R2 represents a hydrogen atom, an alkyl group having 1 to 15 carbon atoms, a hydroxyl group, a nitro group, or an amino group; and R3 represents a hydrogen atom, an alkali metal atom or an alkyl group. The herbicidal composition exert a pharmacological effect for a prolonged period of time, can alleviate or prevent any harmful effect and can reduce the environmental load.
Abstract: Disclosed are an artificial dura mater and manufacturing method thereof. The artificial dura mater includes electrospun layers prepared by electrostatic spinning, at least one of which is a hydrophobic electrospun layer. Further, above the hydrophobic electrospun layer, there can be at least one hydrophilic electrospun layer. A transition layer can be further included between the hydrophobic and the hydrophilic electrospun layers. Additionally, cytokines and/or medicines can be affixed to either or both of the hydrophobic and the hydrophilic electrospun layers, by way of bio-printing. The disclosed artificial dura mater shows good biocompatibility, enhances dural tissue regeneration, achieves excellent repairing effects, prevents adhesion, allows complete absorption, has good mechanical properties, ensures low infection rates, and can be loaded with therapeutic agents.
Type:
Grant
Filed:
February 8, 2010
Date of Patent:
August 5, 2014
Assignee:
Medprin Regenerative Medical Technologies Co., Ltd.
Abstract: Disclosed herein are surgical adjuvant compositions for ameliorating tissue and cellular necrosis and/or apoptosis. In addition, surgical methods are described which include the use of the adjuvant of the composition to reduce tissue and cellular necrosis and/or apoptosis.
Abstract: The instant invention relates to compositions and methods for the control of nematodes and soil borne diseases using compositions comprising high terpene containing oils and one or more surfactants. The invention also relates to methods for increasing the wetted soil volume available for water utilization by plant roots using the disclosed compositions.
Abstract: The present invention relates to boron-containing compositions. The invention relates to comminuted, heterogeneous boron-containing compositions which are obtainable by a process which comprises heating to a temperature sufficiently high that calcination occurs but insufficient for the formation of a homogeneous melt a mixture comprising components capable, under the conditions of heating, of forming the oxides B2O3 and SiO2 and optionally Al2O3, Na2O and/or CaO in proportions such that the relative percentages by weight of the said oxides, based on the total weight of said oxides, are as follows: 5 to 35% B2O3; 10 to 65% SiO2; 0 to 35% Al2O3; and up to 20% Na2O and/or up to 50% CaO; with the proviso that the said B2O3 content is not 10 to 18%, when the other contents are as follows: 40 to 65% SiO2, 17 to 32% Al2O3 4 to 9% Na2O, and 0 to 10% CaO, and then comminuting the resulting composition.
Abstract: The present invention relates to solid dispersions including, but not limited to, co-processed carbohydrates with different solubilities and concentrations, which have a microcrystalline plate structure. The solid dispersions, excipient systems and formulations of the present invention are highly compactable and durable and when compressed into solid dosage forms demonstrate uniform densification, low friability at low pressures, and/or relatively constant low disintegration times at various hardnesses. The solid dosage forms of the present invention demonstrate superior organoleptics, disintegration, and/or robustness.
Abstract: Methods and compositions for treating skin conditions in animals, which tend to have higher skin pH than humans, including wounds, ulcers, rashes, burns, abrasions, and other irritations and relevant injuries are provided. The invention contemplates the use of an aqueous or emollient medium having non-occlusive properties with one or more pH raising ingredients in a composition specifically designed to deliver oxygen to the skin's surface.
Abstract: The present invention relates to pesticidal mixtures comprising as active components 1) at least one isoxazoline compound I of the formula I wherein R1, R2, R3, R4, R5 and A are defined as in the description; and 2) at least one fungicidal compounds II selected from azoles, strobilurins, carboxamides, carbamates, heterocyclic and various other compounds as defined in the description, in synergistically effective amounts. The invention relates further to methods and use of these mixtures for combating insects, arachnids or nematodes and harmful fungis in and on plants, and for protecting such plants being infested with pests, especially also for protecting seeds.
Type:
Grant
Filed:
July 2, 2009
Date of Patent:
December 3, 2013
Assignee:
BASF SE
Inventors:
Karsten Koerber, Florian Kaiser, Egon Haden
Abstract: The present invention relates to the use of three-dimensional microrod scaffolds for the temporal release of growth factors useful in tissue regeneration, engineering and treatment of disorders.
Type:
Grant
Filed:
January 19, 2010
Date of Patent:
November 26, 2013
Assignee:
The Board of Trustees of the University of Illinois
Inventors:
Brenda Russell, Tejal A. Desai, Paul Goldspink
Abstract: Method of exposing agricultural substrates (plant matter 10, animal matter 12) to agrochemicals (A); method of decreasing or preventing sub-surface geological matter (20, 22) contamination resulting from exposing agricultural substrates to agrochemicals; composition [(A)/(T)] 30 used therein; article-of-manufacture including the composition. Includes exposing agricultural substrates to composition including combination (mixture) of an agrochemical and at least one transforming agent capable of decreasing or eliminating concentration of the agrochemical which contacts sub-surface geological matter (at temporally varying times, and at spatially varying depths). Before entering sub-surface geological matter, transforming agent exhibits inactivity for decreasing agrochemical concentration, and inactivity for affecting or/and interfering with agrochemical functionality with respect to agricultural substrates.